NEW YORK ( TheStreet) -- Enzon Pharmaceuticals (Nasdaq: ENZN) hit a new 52-week low Thursday as it is currently trading at $7.38, below its previous 52-week low of $7.42 with 129,976 shares traded as of two p.m. ET. Average volume has been 377,600 shares over the past 30 days. Enzon has a market cap of $384.6 million and is part of the health care sector and drugs industry. Shares are down 36.7% year to date as of the close of trading on Wednesday. Enzon Pharmaceuticals, Inc., a biotechnology company, engages in the research and development of therapeutics for cancer patients with unmet medical needs.
- Practice your ENZN trading strategies and win cash in our stock game.